Literature DB >> 19531452

Linguistic adaptation and validation of the Spanish version of the Memorial Pain Assessment Card (MPAC).

Yolanda Escobar1, Manuel Domine, Jorge Contreras, Francisco Valcárcel.   

Abstract

INTRODUCTION: The Memorial Pain Assessment Card (MPAC), validated in 1987, is a card utilised for the self-assessment of cancer pain. The MPAC provides a quick, reliable measure of quality of life.
MATERIALS AND METHODS: This study is a linguistic adaptation of the original version of the MPAC into the Spanish language and its validation. This was a multicentre, cross-sectional, observational study. Linguistic adaptation was carried out by four independent translators and two medical oncologists. The MPAC includes 4 subscales: three are visual analogue scales (VAS) measuring pain relief (VASPR), pain intensity (VASPI) and mood (VASMOOD). A fourth subscale consists of a set of pain severity descriptors (Tursky scale).
RESULTS: VASPR has been validated in a subsequent prospective follow-up study. The validation of the MPAC subscales included: reliability (Cronbach's coefficient), internal validation (Spearman's coefficient) and external validation (McGill Pain Questionnaire, MPQ; Profile of Mood States, POMS; Hamilton Depression Scales, HDRS; and Zung Anxiety Scale, ZAS). A moderately high reliability of the VASPI, Tursky and VASMOOD subscales (alpha=0.72) was observed. Regarding internal validity, VASPI correlated significantly with Tursky and VASMOOD. However, they showed a non-significant correlation between each other. Regarding external validity, VASPI, Tursky and VASMOOD were correlated with most of the MPQ subscales. VASMOOD and Tursky correlated with most of the POMS subscales, but not with HDRS or ZAS. VASPI showed a non-significant correlation with all of the psychological distress measures.
CONCLUSIONS: Our findings showed a successful validation of the VASPI, VASMOOD and Tursky subscales of the MPAC Spanish version.

Entities:  

Mesh:

Year:  2009        PMID: 19531452     DOI: 10.1007/s12094-009-0371-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  14 in total

1.  Profile of Mood States: the factors and their physiological correlates.

Authors:  V Pollock; D W Cho; D Reker; J Volavka
Journal:  J Nerv Ment Dis       Date:  1979-10       Impact factor: 2.254

2.  [Instrument for the measure of quality of life in cancer patients].

Authors:  Y Agra Varela; X Badía Llach; A Gil Miguel
Journal:  Med Clin (Barc)       Date:  1998-05-23       Impact factor: 1.725

3.  The measurement of affects: depression and anxiety.

Authors:  W W Zung
Journal:  Mod Probl Pharmacopsychiatry       Date:  1974

4.  An exploratory study of frequent pain measurement in a cancer clinical trial.

Authors:  J Ingham; A Seidman; T J Yao; J Lepore; R Portenoy
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

5.  Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor.

Authors:  A D Seidman; R Portenoy; T J Yao; J Lepore; E K Mont; J Kortmansky; N Onetto; L Ren; J Grechko; M Beltangady
Journal:  J Natl Cancer Inst       Date:  1995-09-06       Impact factor: 13.506

6.  Quality of life of women with ovarian cancer.

Authors:  A B Kornblith; H T Thaler; G Wong; V Vlamis; J M Lepore; D B Loseth; T Hakes; W J Hoskins; R K Portenoy
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

7.  Pain measurement: an overview.

Authors:  C R Chapman; K L Casey; R Dubner; K M Foley; R H Gracely; A E Reading
Journal:  Pain       Date:  1985-05       Impact factor: 6.961

8.  The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain.

Authors:  B Fishman; S Pasternak; S L Wallenstein; R W Houde; J C Holland; K M Foley
Journal:  Cancer       Date:  1987-09-01       Impact factor: 6.860

9.  Sensivity to change of the Spanish validated Memorial Pain Assessment Card in cancer patients.

Authors:  Jorge Contreras; Francisco Valcárcel; Manuel Dómine; Yolanda Escobar
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

Review 10.  Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment.

Authors:  M Michael; I F Tannock
Journal:  CMAJ       Date:  1998-06-30       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.